Dickon Pharmaceutical Co., 10 ext. 15 Trading Today

NetEase Finance March 3 News Dickon Pharmaceutical industry recently released the 2010 Annual report.　　Although the cumulative profit for shareholders at the end of last year was negative, the company is still intending to increase by 15 shares per 10 shares.　　The announcement shows that the Dickon pharmaceutical industry in 2010 to achieve business income of 322 million yuan, an increase of 2.48%, net profit of 30.9665 million yuan, increased by 110.8%, excluding non-recurrent income after the net profit of only 15.4228 million yuan, the basic earnings per share of 0.1763 yuan, net assets yield of 6.16%. Although the operating performance is not brilliant, Dickon pharmaceutical industry has put forward enough to make the market stunning bonus plans. The company said in its annual report that due to the cumulative end of 2010 for shareholders to allocate profits of 81.106 million yuan, the company's profits will be all used to make up the previous losses, so can not make profit distribution.　　However, "comprehensive consideration of the long-term development of the company, the return of shareholders and other factors", the company intends to use Provident Fund 10 shares to increase 15 shares. While many of the listed companies have offered high transfers this year, it is not much of a generous move to increase equity. According to wind statistics, as of March 2, only the golden channeling (300091, closing price of 55.20 Yuan), Juloka (300099, closing price of 111.80 yuan), Sino-Swiss Thinking (300078, Closing price of 83.15 yuan) 3 companies proposed the increase in capital accumulation of 10 to 15, and these three companies are listed last year gem new shares.　　In addition, the Wuzhou Pearl (600873, closing price of 41.36 Yuan) proposed 10 to 16.86, is currently the largest shares.　　Secondary market, the stock trading today. Related news Andy Kang pharmaceutical industry no money dividend push high send to 10 ext. 15